0001415889-18-000948.txt : 20180618
0001415889-18-000948.hdr.sgml : 20180618
20180618160022
ACCESSION NUMBER: 0001415889-18-000948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180617
FILED AS OF DATE: 20180618
DATE AS OF CHANGE: 20180618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASEY MICHAEL D
CENTRAL INDEX KEY: 0001190435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 18904517
MAIL ADDRESS:
STREET 1: ALLOS THERAPEUTICS, INC.
STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
form4-06182018_040606.xml
X0306
4
2018-06-17
0000816284
CELGENE CORP /DE/
CELG
0001190435
CASEY MICHAEL D
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
true
false
false
false
Common Stock
2018-06-17
4
M
0
334
0
A
0
D
Common Stock
117813
I
By Family Trust
Restricted Stock Unit
2018-06-17
4
M
0
334
0
D
Common Stock
334
0
D
The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock.
334 shares were transferred to the Casey Family Trust U/A Dated 12/28/2004.
The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan).
/s/ Peter N. Kellogg, Attorney-in-Fact
2018-06-18